FSK vs GILD · $3.04B cap vs P/E 18, rev $7.80B
FS KKR Capital Corp (FSK) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
FS KKR Capital Corp (FSK) is a asset management company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
FSK does not have a complete income-statement cache yet.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FSK currently screens at market cap $3.04B. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FSK and GILD stock pages for the full models.
Not investment advice.